Minodronate Suppresses Prostaglandin F2α-induced Vascular Endothelial Growth Factor Synthesis in Osteoblasts

Y. Hanai; H. Tokuda; S. Takai; A. Harada; T. Ohta; O. Kozawa

doi:10.1055/s-2006-925177

Hormone and Metabolic Research, Inhaltsverzeichnis

Horm Metab Res 2006; 38(3): 152-158
DOI: 10.1055/s-2006-925177

Original Basic

Minodronate Suppresses Prostaglandin F2α-induced Vascular Endothelial Growth Factor Synthesis in Osteoblasts

Y. Hanai^1, ² , H. Tokuda^1, ² , S. Takai¹ , A. Harada³ , T. Ohta⁴ , O. Kozawa¹

¹Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan
²Department of Clinical Laboratory, National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Aichi, Japan
³Functional Restoration, National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Aichi, Japan
⁴Internal Medicine, National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Aichi, Japan

Abstract

In our previous study, we showed that prostaglandin F_2α (PGF_2α) stimulates vascular endothelial growth factor (VEGF) synthesis via activation of p44/p42 mitogen-activated protein (MAP) kinase via protein kinase C (PKC) in osteoblast-like MC3T3-E1 cells. In addition, we demonstrated that incadronate amplified, and tiludronate suppressed PGF_2α-induced VEGF synthesis among bisphosphonates, while alendronate or etidronate had no effect. In the present study, we investigated the effects of minodronate, a newly developed bisphosphonate, on PGF_2α-induced VEGF synthesis in MC3T3-E1 cells. Minodronate significantly reduced VEGF synthesis induced by PGF_2α dose-dependently at levels between 3 and 100 µM. PGF_2α-stimulated phosphorylation of Raf-1, MEK1/2 and p44/p42 MAP kinase were suppressed by minodronate. 12-O-tetradecanoylphorbol-13-acetate (TPA), a direct activator VEGF synthesis induced by PKC, was inhibited by minodronate. Minodronate inhibited Raf-1, MEK1/2 and p44/p42 MAP kinase phosphorylation induced by TPA. Mevalonate failed to affect the suppressive effect of minodronate on PGF_2α-induced VEGF synthesis. Taken together, these results indicate that minodronate suppresses PGF_2α-stimulated VEGF synthesis at the point between PKC and Raf-1 in osteoblasts.

Key Words

Bisphosphonate - prostaglandin F_2α - vascular endothelial growth factor - osteoblast

Volltext

Referenzen

References

1 Nijweide P J, Burger E H, Feyen J HM. Cells of bone: Proliferation, differentiation and hormonal regulation. Physiol Rev. 1986; 66 855-886
2 Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie M T, Martin T J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev. 1999; 20 345-357
3 Erlebacher A, Filvaroff E H, Girelman S E, Derynck R. Toward a molecular understanding of skeletal development. Cell. 1995; 80 371-378
4 Fleisch H, Reszka A, Rodan G A, Rogers M. Bisphosphonates. In: Bilezikian JP, Ratsz LG, Rodan GA (eds) Principles of Bone Biology 2nd Ed. San Diego, CA; Academic Press 2002: 1361-1385
5 Sahni M, Guenther H L, Fleisch H, Collin P, Martin T J. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest. 1993; 91 2004-2011
6 Nishikawa M, Akatsu T, Katayama Y, Yasutomo Y, Kado S, Kugai N, Yamamoto M, Hagata N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone. 1995; 18 9-14
7 Vitte C, Fleisch H, Guenther H L. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology. 1996; 137 2324-2333
8 Tokuda H, Kozawa O, Harada A, Uematsu T. Minodronate inhibits interleukin-6 synthesis in osteoblasts: Inhibition of phospholipase D activation in MC3T3-E1 cells. J Cell Biochem. 1998; 69 252-259
9 Plotkin L I, Weinstein R S, Parfitt A M, Roberson P K, Manolagas S C, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999; 104 1363-1374
10 Reinholz G G, Getz B, Pederson L, Sanders E S, Subramaniam M, Ingle J N, Spelsberg T C. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res. 2000; 60 6001-6007
11 Viereck V, Emos G, Lauck V, Frosch K H, Blaschke S, Grundker C, Hofbauer L C. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun. 2002; 291 680-686
12 Mackie P S, Fisher J L, Zhou H, Choong P F. Bisphosphonates regulate cell growth and gene expression in the UMR 106 - 01 clonal rat osteosarcoma cell line. Br J Cancer. 2001; 84 951-958
13 Pan B, To L B, Farrugia A N, Findlay D M, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins G J, Zannettino A CW. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralization of human bone-derived cells in vitro. Bone. 2004; 34 112-123
14 Pan B, Farrugia A N, To L B, Findlay D M, Green J, Lynch K, Zannettino A CW. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-α converting enzyme (TACE). J Bone Miner Res. 2004; 19 147-154
15 Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev. 1997; 18 4-25
16 Gerber H P, Vu T H, Ryan A M, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999; 5 623-662
17 Harada S, Thomas K A. Vascular endothelial growth factors. In: Bilezikian JP, Ratsz LG, Rodan GA (eds) Principles of Bone Biology 2nd Ed. San Diego, CA; Academic Press 2002: 883-902
18 Miwa M, Tokuda H, Tsushita K, Kotoyori J, Takahashi Y, Ozaki N, Kozawa O, Oiso Y. Involvement of pertussis toxin-sensitive GTP-binding protein in prostaglandin F_2α-induced phosphoinositide hydrolysis in osteoblast-like cells. Biochem Biophys Res Commun. 1990; 171 1229-1235
19 Kozawa O, Suzuki A, Kotoyori J, Tokuda H, Watanabe Y, Ito Y, Oiso Y. 1994 Prostaglandin F_2α activates phospholipase D independently from activation of protein kinase C in osteoblast-like cells. J Cell Biochem. 1994; 55 373-379
20 Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992; 258 607-614
21 Exton J H. Regulation of phospholipase D. Biochim Biophys Acta. 1999; 1439 121-133
22 Tokuda H, Harada A, Hirade K, Matsuno H, Ito H, Kato K, Oiso Y, Kozawa O. Incadronate amplifies prostaglandin F_2α-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity. J Biol Chem. 2003; 278 18 930-18 937
23 Yoshida M, Tokuda H, Ishisaki A, Kanno Y, Harada A, Shimuzu K, Kozawa O. Tiludronate inhibits prostaglandin F_2α-induced vascular endothelial growth factor synthesis in osteoblasts. Mol Cell Endocrinol. 2005; 236 59-66
24 Sudo M, Kodama H, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983; 96 191-198
25 Kanno Y, Ishisaki A, Yoshida M, Nakajima K, Tokuda H, Numata O, Kozawa O. Adenylyl cyclase-cAMP system inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts. Mol Cell Endocrinol. 2005; 229 75-82
26 Noda T, Tokuda H, Yoshida M, Yasuda E, Hanai Y, Takai S, Kozawa O. Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts. Horm Metab Res. 2005; 37 270-274
27 Kozawa O, Suzuki A, Tokuda H, Uematsu T. Prostaglandin F_2α stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol. 1997; 272 E208-E211
28 Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227 680-685
29 Kato K, Ito K. , Hasegawa K, Inaguma Y, Kozawa O, Asano T. Modulation of the stress-induced synthesis of hsp27 and αB-crystalin by cyclic AMP in C6 rat glioma cells. J Neurochem. 1996; 66 946-950
30 Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986; 233 305-312
31 Hatakeyama D, Kozawa O, Otsuka T, Shibata T, Uematsu T. Zinc suppresses IL-6 synthesis by prostaglandin F2α in osteoblasts: inhibition of phospholipase C and phospholipase D. J Cell Biochem. 2002; 85 621-628
32 Widmann C, Gibson S, Jarpe M B, Johnson G L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999; 79 143-180
33 Marx R E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003; 61 1115-1118
34 Carter G D, Goss A N. Bisphosphonates and avascular necrosis of the jaws. Aust Dent J. 2003; 48 268
35 Tokuda H, Kozawa O, Harada A, Uematsu T. p42/p44 mitogen-activated protein kinase activation is involved in prostaglandin F_2α-induced interleukin-6 synthesis in osteoblasts. Cell Signal. 1999; 11 325-330

Osamu Kozawa

Department of Pharmacology · Gifu University Graduate School of Medicine

1-1 Yanagido · Gifu 501-1194 · Japan

Telefon: +81 (58) 230-6214

Fax: +81 (58) 230-6215

eMail: okozawa@cc.gifu-u.ac.jp